PhRMA goes on the offensive, attacking the WHO and putting the EU, UK, Australia and others on notice
Each year, industry groups like PhRMA offer their views on which countries around the globe might be harming biopharma innovation as a result of their intellectual property protections or lack thereof, which can contribute to a report produced by the White House’s trade representative on the global state of IP.
This year’s 273 pages worth of comments from PhRMA not only take issue with the Biden administration’s pledge to support an IP waiver for Covid-19 vaccines at the WTO, but also raise concerns about the WHO and other countries on the priority watch list, like Canada, and the industry group has requested that the US trade representative add Australia, Taiwan, the EU, UK, Egypt and Israel to its “watch list.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.